Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal mucosa and stool interface is the physiological boundary where the host's intestinal epithelium meets the luminal contents, including the gut microbiota and fecal matter. This interface is primarily composed of a protective mucus layer that acts as a selective filter, allowing for the absorption of nutrients while preventing the translocation of pathogens and pro-inflammatory antigens into the systemic circulation (Johansson et al., 2015, Nature Reviews Gastroenterology & Hepatology). It plays a vital role in immune homeostasis by facilitating cross-talk between commensal bacteria and the mucosal immune system (Belkaid & Hand, 2014, Cell). Pathological alterations at this interface, such as mucus depletion or increased epithelial permeability, are central to the pathogenesis of inflammatory bowel disease and other metabolic disorders (Turner, 2009, Nature Reviews Immunology). Although it is a complex microenvironment rather than a single molecular target, it is the focus of therapeutic strategies like fecal microbiota transplantation and mucosal protectants designed to restore barrier integrity and microbial balance (Groschwitz & Hogan, 2009, Journal of Allergy and Clinical Immunology).
Modulation of the gut microbiota, reinforcement of the mucus layer, and stabilization of the intestinal epithelial barrier to prevent antigen translocation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal mucosa and stool interface.